PRE PRENETICS GLOBAL LIMITED

Prenetics Unveils IM8 to U.S. Consumers with Co-Founding Partner David Beckham

Prenetics Unveils IM8 to U.S. Consumers with Co-Founding Partner David Beckham

The Next Big Thing in Wellness? IM8 Lands in the U.S. with a Star-Studded Launch. David Beckham and a world-class scientific team are putting the focus back on foundational health

CHARLOTTE, N.C., Jan. 21, 2025 (GLOBE NEWSWIRE) -- , a premium supplements brand co-founded by David Beckham, hosted its U.S. unveiling event in New York City on January 14. The two-part event featured an Inside Out Wellness session with holistic health advocate Deepak Chopra, M.D., and David Beckham, followed by An Evening with IM8 featuring stage conversations with IM8’s (SAB) and co-founding partner of IM8, David Beckham. This event solidified the brand's U.S. presence following .

The IM8 Inside Out Wellness session included a tasting of the company’s hero product, , a meditation session with Deepak Chopra, and a conversation between best-selling author and fitness personality, Tunde Oyeneyin, and David Beckham about his wellness journey with IM8. 

The evening event featured a panel moderated by Emily Goldman, Deputy Editor at Prevention Magazine with Dr. Dawn Mussallem, Dr. Suzanne Devkota, and Dr. James DiNicolantonio of IM8’s Scientific Advisory Board. Following the SAB panel, co-founding partner, David Beckham sat down with Fast Company Senior Editor, Jeff Beer, to discuss why he wanted to become a co-founding partner of IM8, the importance of IM8's strong scientific foundation, and how his health journey has evolved throughout his career as a professional athlete.

Customer interest in IM8 surged after David Beckham appeared on the and when health, fitness and lifestyle influencers shared the IM8 story with their global audiences. This comes on the heels of , a globally recognized standard for supplement safety, quality, and transparency.

“Today is about more than just launching a product. It’s about starting a movement—a commitment to empowering people to live healthier, more vibrant lives,” said IM8 co-founding partner and CEO, Danny Yeung.

"I’ve been drinking IM8 every day for six months, and I feel the difference. Health has always been a priority for me, and with IM8, we set out to create something truly effective. Backed by science, built for daily life—IM8 works,” said IM8 co-founding partner David Beckham.

Event Imagery:

Press Kit:

Press Contact:

Jack Taylor

Public Relations

 

Angela Cheung

Investor Relations / Corporate Finance

Prenetics Global Limited

About IM8

IM8 is the pinnacle of premium core nutrition, born from a collaboration between David Beckham as a co-founding partner, and an elite team of scientists spanning medical professionals, academia and space science. Combining cutting-edge science with nature’s most potent ingredients, IM8 delivers a holistic, science-backed approach to health, empowering you to live your most vibrant life.



EN
21/01/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on PRENETICS GLOBAL LIMITED

 PRESS RELEASE

Prenetics Announces Third Quarter 2025 Financial Results Release Date ...

Prenetics Announces Third Quarter 2025 Financial Results Release Date and Inaugural Earnings Conference Call CHARLOTTE, N.C., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or the “Company”), a leading health sciences company, today announced it will release financial results for the third quarter 2025 ended September 30, 2025 before market open on Monday, November 10, 2025. The Company will also hold its first ever earnings conference call the same day at 8:30 a.m. Eastern Time to discuss its financial results in further detail. The call will conclu...

 PRESS RELEASE

Prenetics’ IM8 Achieves Record $9 Million in Revenue for October, Surp...

Prenetics’ IM8 Achieves Record $9 Million in Revenue for October, Surpasses $108 Million in Annualized Recurring Revenue 11 Months After Launch ~ October Revenue Grew 32% MoM and on Track to hit $10 Million in Monthly Revenue by December 2025 ~ CHARLOTTE, N.C., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Prenetics Global Limited (Nasdaq: PRE) (“Prenetics”), a leading health sciences company and parent of the IM8 premium health and longevity brand, today announced a record breaking month for IM8 in October, reaching approximately $108 million in annualized recurring revenue (ARR) just 11 months aft...

 PRESS RELEASE

Prenetics Bolsters Bitcoin Treasury with Strategic Acquisition of 100 ...

Prenetics Bolsters Bitcoin Treasury with Strategic Acquisition of 100 Bitcoin, IM8 Reaches $100M ARR Additional Bitcoin Acquisition Follows Immediately on $44 Million Equity Offering Company now holds a total of 378 BTC (valued at ~$46 Million) CHARLOTTE, N.C., Oct. 31, 2025 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or the “Company”), a leading health sciences company, today announces the acquisition of 100 Bitcoin, at an average price of $109,594 per Bitcoin. This acquisition demonstrates the Company's dedication and continued discipline to building its Bi...

 PRESS RELEASE

Prenetics CEO Danny Yeung Publishes "The Dual-Engine Revolution" Manif...

Prenetics CEO Danny Yeung Publishes "The Dual-Engine Revolution" Manifesto: A Blueprint for the Future of Health + Wealth Comprehensive Document Reveals Strategic Vision Behind Company's Unprecedented Growth and Bitcoin Treasury Strategy IM8, the Fastest-Growing Supplement Brand in Industry History, Reaching Reaches $100M ARR in 11 Months Since Launch IM Projects $180-$200 Million in FY 2026 Revenue CHARLOTTE, N.C., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE (“Prenetics” or the “Company”), a leading health sciences company, today announced the publication o...

 PRESS RELEASE

Prenetics Announces Closing of Approx. $44.0 Million Equity Offering t...

Prenetics Announces Closing of Approx. $44.0 Million Equity Offering to Fuel IM8’s Global Expansion and Bitcoin Treasury Strategy CHARLOTTE, N.C., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or the “Company”), a leading health sciences company, today announced the closing of its previously announced best efforts public offering (the “Offering”) of (i) 2,722,642 Class A ordinary shares, par value $0.0015 per share, of the Company (the “Ordinary Shares,” the Ordinary Shares being sold in the Offering, the “Shares”), (ii) warrants of the Company to p...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch